CLSD, NGM

Clearside Biomedical, Inc. (CLSD)

Price (as of October 30)

1.14USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

BNOX

Bionomics Limited

-0.18

ANTX

AN2 Therapeutics, Inc.

-0.15

ABCL

AbCellera Biologics Inc.

-0.08

ACXP

Acurx Pharmaceuticals, Inc.

-0.08

ADCT

ADC Therapeutics SA

-0.07

APM

Aptorum Group Limited

-0.06

BGNE

BeiGene, Ltd.

-0.05

ATAI

Atai Life Sciences N.V.

-0.05

CGEM

Cullinan Oncology, Inc.

-0.05

MRNA

Moderna, Inc.

-0.05

Show more

Highest within Industry

Symbol Correlation

BLTE

Belite Bio, Inc

0.22

BWV

Blue Water Vaccines, Inc.

0.12

BTTX

Better Therapeutics, Inc.

0.12

BPTS

Biophytis S.A.

0.1

AVTE

Aerovate Therapeutics, Inc.

0.1

APRE

Aprea Therapeutics, Inc.

0.09

APLT

Applied Therapeutics, Inc.

0.09

ADGI

Adagio Therapeutics, Inc.

0.07

CASI

CASI Pharmaceuticals, Inc.

0.06

SGEN

Seagen Inc.

0.06

Show more

Profile

Sector:
Healthcare
Industry:
Biotechnology

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.